Creating artificial enzymes to selectively break down carbohydrates
Artificial Glycosidase with Controlled Selectivity
This study is working on creating special tiny particles that can help break down sugars in a targeted way, which could improve our understanding of how sugars affect health and diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa State University NIH-funded |
| Lab location | 1 site (Ames, United States) |
| Project ID | NIH-10679086 on NIH RePORTER |
What this research studies
This research focuses on developing artificial glycosidases, which are enzymes designed to selectively break down carbohydrates. By utilizing protein-sized molecularly imprinted nanoparticles, the project aims to create synthetic lectins that can recognize and bind various carbohydrates and peptides. The methodology involves preparing these nanoparticles quickly and efficiently, allowing for the distinction of oligosaccharides based on their structure and composition. This innovative approach seeks to enhance our understanding of glycans and their roles in biological processes and diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions related to carbohydrate metabolism or diseases influenced by glycan interactions.
Not a fit: Patients with conditions unrelated to carbohydrate metabolism or glycan biology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved tools for studying carbohydrates, potentially impacting treatments for diseases related to glycan dysfunction.
How similar studies have performed: Other research has shown promise in developing synthetic enzymes for carbohydrate interactions, indicating a potential for success in this novel approach.
Where this research is happening
Ames, United States
- Iowa State University — Ames, United States (Active)
Researchers
- Principal investigator: Zhao, Yan — Iowa State University
- Study coordinator: Zhao, Yan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.